Free Immunoglobulin Light Chains as Criteria of Extracorporeal Hemocorrection in Patients with Monoclonal Gammopathies
- Authors: Lyubimova N.V.1, Timofeeva Y.S.1, Gromova E.G.1, Kuznetsova L.S.1, Votyakova O.M.1, Kushlinskii N.E.1
- 
							Affiliations: 
							- N. N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation
 
- Issue: Vol 163, No 4 (2017)
- Pages: 493-496
- Section: Experimental Methods for Clinical Practice
- URL: https://journals.rcsi.science/0007-4888/article/view/239033
- DOI: https://doi.org/10.1007/s10517-017-3836-5
- ID: 239033
Cite item
Abstract
Elimination of free immunoglobulin light chains with the use of EMic2 selective filters was carried out in 12 patients with monoclonal gammopathies and high production of free immunoglobulin light chains. We showed that extracorporeal detoxification for direct removal of excessive free immunoglobulin light chains from the circulation is advisable for these patients, irrespective of the presence and severity of renal insufficiency. Rapid reduction or elimination of free light chains of immunoglobulins in the course of selective extracorporeal elimination helps to prevent the development of irreversible renal failure and to perform adequate antitumor therapy.
About the authors
N. V. Lyubimova
N. N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation
														Email: biochimia@yandex.ru
				                					                																			                												                	Russian Federation, 							Moscow						
Yu. S. Timofeeva
N. N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation
														Email: biochimia@yandex.ru
				                					                																			                												                	Russian Federation, 							Moscow						
E. G. Gromova
N. N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation
														Email: biochimia@yandex.ru
				                					                																			                												                	Russian Federation, 							Moscow						
L. S. Kuznetsova
N. N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation
														Email: biochimia@yandex.ru
				                					                																			                												                	Russian Federation, 							Moscow						
O. M. Votyakova
N. N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation
														Email: biochimia@yandex.ru
				                					                																			                												                	Russian Federation, 							Moscow						
N. E. Kushlinskii
N. N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation
							Author for correspondence.
							Email: biochimia@yandex.ru
				                					                																			                												                	Russian Federation, 							Moscow						
Supplementary files
 
				
			 
					 
						 
						 
						 
						 
				 
  
  
  
  
  Email this article
			Email this article  Open Access
		                                Open Access Access granted
						Access granted Subscription Access
		                                		                                        Subscription Access
		                                					